Evidence map›Paper›PMID 24035486›Full record

ArticleBioorganic & medicinal chemistry letters2013

REDOR NMR for drug discovery.

Lynette Cegelski

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Conformational Dynamics of BacteriochlorophyllThe journal of physical chemistry. B · 2025
    Article
  3. Tigliane Diterpenoids.Progress in the chemistry of organic natural products · 2024
    Review
  4. Article
  5. Review
  6. Off-resonanceJournal of biomolecular NMR · 2021
    Article
  7. Solid-state NMR spectroscopy.Nature reviews. Methods primers · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The journal of physical chemistry. B · 2017
    Article
  14. The Application of REDOR NMR to Understand the Conformation of Epothilone B.International journal of molecular sciences · 2017
    Article
  15. Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
  16. Article
  17. Article
  18. Membrane protein structure from rotational diffusion.Biochimica et biophysica acta · 2015
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lynette CegelskiDepartment of Chemistry, Stanford University, Stanford, CA 94305, USA. Electronic address: cegelski@stanford.edu.

Funding

Structure, Function, and Disruption of Microbial Amyloid Assembly and Biofilm ForDP2OD007488 · OD · STANFORD UNIVERSITY · PI CEGELSKI, LYNETTE S · 2010 to 2010
$2.4M
NIH HHS DP2 OD007488NIH HHS DP2OD007488
6 · The paper itself

Abstract

Rotational-echo double-resonance (REDOR) NMR is a powerful and versatile solid-state NMR measurement that has been recruited to elucidate drug modes of action and to drive the design of new therapeutics. REDOR has been implemented to examine composition, structure, and dynamics in diverse macromolecular and whole-cell systems, including taxol-bound microtubules, enzyme-cofactor-inhibitor ternary complexes, and antibiotic-whole-cell complexes. The REDOR approach involves the integrated design of specific isotopic labeling strategies and the selection of appropriate REDOR experiments. By way of example, this digest illustrates the versatility of the REDOR approach, with an emphasis on the practical considerations of experimental design and data interpretation.

Indexed as

Anti-Bacterial AgentsBinding SitesDrug DiscoveryHumansMicrotubulesModels, MolecularNuclear Magnetic Resonance, BiomolecularPaclitaxelStaphylococcal InfectionsStaphylococcus aureusTubulin ModulatorsVancomycinAnti-Bacterial AgentsPaclitaxelTubulin ModulatorsVancomycinDrug discoveryREDORSolid-state NMRTaxolVancomycinWhole-cell NMR

Identifiers

PMID24035486
PMCPMC4038398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.